|
| |
Malignant CarcinoidDownload PDF containing detailed information.
Recent Publications on Malignant Carcinoid: |  |
Case of carcinoid crisis following a fine-needle biopsy of hepatic metastasis.
Fine-needle biopsy of hepatic lesions in a patient with carcinoid liver... | 10th September, 2009
| Department of Nephrology, Princess Alexandra Hospital, Woolloongabba,
| Eur J Gastroenterol Hepatol. 2009 Jan;21(1):101-3.
|
Carcinoid syndrome.
BACKGROUND: Octreotide LAR is an established treatment for malignant... | 23rd July, 2009
| Department of Internal Medicine, Regina General Hospital, Regina
| CMAJ. 2009 Jun 23;180(13):1329.
DOI Direct Link |
Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR.
BACKGROUND: Octreotide LAR is an established treatment for malignant... | 4th July, 2009
| Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK.
| Aliment Pharmacol Ther. 2009 Oct;30(7):733-40. Epub 2009 Jul 2.
DOI Direct Link |
[Rectal carcinoids on the rise - update]
Rectal carcinoids are becoming more common: in the USA they have increased... | 27th June, 2009
| Klinik fur Innere Medizin - Gastroenterologie und GI Onkologie,
| Z Gastroenterol. 2009 Apr;47(4):365-71. Epub 2009 Apr 8.
DOI Direct Link |
Incidental malignant carcinoid within Crohn ileitis.
BACKGROUND: Octreotide LAR is an established treatment for malignant... | 26th June, 2009
| Departments of General Surgery, Vernon Jubilee Hospital, Vernon, BC.
| Can J Surg. 2009 Jun;52(3):E58-9.
|
→View more research publications. |
Press Releases About Malignant Carcinoid:
|
 |
| FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma |
5th October, 2009 |
Schering-Plough Corp. |
GAITHERSBURG, Md., Oct. 5, /PRNewswire-FirstCall/ -- Schering-Plough Corp. (NYSE: SGP) announced today that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC)
|
| Newly Published Phase III Data Show Novartis Drug Sandostatin(R) LAR Depot Reduced Risk of Disease Progression by 66% in Advanced NET Patients |
1st October, 2009 |
Novartis Pharmaceuticals Corporation |
9. American Cancer Society. Detailed Guide: Gastrointestinal Carcinoid
Tumors. What are the key statistics about gastrointestinal carcinoid
tumors?
http://www.cancer.org
|
| JHP Pharmaceuticals Introduces a Dantrium(R) IV (dantrolene sodium for injection), Rapidly Mixing at 20 Seconds |
28th September, 2009 |
JHP Pharmaceuticals, LLC |
-- Easier and faster introduction of diluent into the Dantrium® IV vial
JHP has also introduced two new features in the Dantrium® IV vial; an easy-to-open flip-off vial cap and an easy-to
|
| Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report |
24th September, 2009 |
Reportlinker |
-- SERMS
The report includes market share by type of cancer and market share by company for each of the three major segments. It also includes statistical information for cancers by type
|
| SCHERING-PLOUGH ANNOUNCES FDA APPROVAL OF SAPHRIS(R) (asenapine): for acute treatment of schizophrenia in adults and manic or mixed episodes of bipolar I disorder with or without psychotic features in adults |
14th August, 2009 |
Schering-Plough |
Schering-Plough Corporation (NYSE: SGP) today announced that the U.S.
Food and Drug Administration (FDA) has approved SAPHRIS(R) (asenapine)
sublingual tablets for acute treatment of schizophrenia
|
BioPortfolio Ltd. offers e-mail and postal lists for Malignant Carcinoid scientists - we have details of around 177 individuals working on Malignant Carcinoid .
This page has been viewed 238 times
Recent Search Terms used to find this page: carcinoid | untreatable carcinoid tumor | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Malignant Carcinoid across BioPortfolio, or for Malignant Carcinoid Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
